Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $51.92 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $20.05 | 1 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.42 | 1 | $0 (2024) |
| Novo Nordisk Inc | $13.45 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.42 | 1 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($18.42) |
| 2023 | $33.50 | 2 | ABBVIE INC. ($20.05) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2023 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 259 | 267 | $61,940 | $17,647 |
| 2022 | 4 | 325 | 330 | $330,658 | $35,141 |
| 2021 | 5 | 468 | 477 | $456,731 | $51,454 |
| 2020 | 5 | 544 | 560 | $556,418 | $58,225 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 44 | $7,001 | $3,961 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 61 | $7,109 | $3,687 | 51.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $6,747 | $2,964 | 43.9% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 17 | 17 | $26,350 | $2,490 | 9.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 26 | 26 | $4,319 | $1,149 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,721 | $1,140 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $1,920 | $775.23 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 19 | $2,356 | $732.96 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,296 | $644.63 | 49.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 18 | 18 | $1,122 | $103.52 | 9.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 138 | 140 | $209,420 | $21,909 | 10.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 51 | 52 | $94,252 | $10,583 | 11.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 19 | 19 | $19,177 | $1,872 | 9.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 117 | 119 | $7,809 | $776.97 | 9.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 202 | 203 | $288,959 | $32,662 | 11.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 64 | 64 | $116,734 | $13,691 | 11.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 32 | 33 | $32,149 | $3,271 | 10.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 156 | 163 | $11,247 | $1,051 | 9.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 14 | 14 | $7,642 | $778.67 | 10.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 232 | 235 | $335,235 | $34,722 | 10.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 98 | 100 | $183,838 | $19,697 | 10.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 18 | 18 | $17,454 | $1,823 | 10.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 184 | 195 | $13,455 | $1,331 | 9.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 12 | 12 | $6,436 | $652.50 | 10.1% |
About Dr. Ryan Macdonald, M.D
Dr. Ryan Macdonald, M.D is a Emergency Medicine healthcare provider based in Athol, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1255565933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Macdonald, M.D has received a total of $51.92 in payments from pharmaceutical and medical device companies, with $18.42 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($51.92).
As a Medicare-enrolled provider, Macdonald has provided services to 1,596 Medicare beneficiaries, totaling 1,634 services with total Medicare billing of $162,466. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Athol, ID
- Active Since 05/08/2009
- Last Updated 04/16/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1255565933
Products in Payments
- VIBERZI (Drug) $20.05
- CAPLYTA (Drug) $18.42
- Rybelsus (Drug) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.